These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 32343493)
61. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026 [TBL] [Abstract][Full Text] [Related]
62. Plasma miRNAs as biomarkers for endometriosis. Vanhie A; O D; Peterse D; Beckers A; Cuéllar A; Fassbender A; Meuleman C; Mestdagh P; D'Hooghe T Hum Reprod; 2019 Sep; 34(9):1650-1660. PubMed ID: 31411334 [TBL] [Abstract][Full Text] [Related]
63. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study. Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537 [TBL] [Abstract][Full Text] [Related]
64. A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome. Emmi G; Bagni G; Lastraioli E; Di Patti F; Bettiol A; Fiorillo C; Becatti M; Silvestri E; Urban ML; Emmi L; Prisco D; Arcangeli A Ann Rheum Dis; 2022 Mar; 81(3):386-397. PubMed ID: 34844932 [TBL] [Abstract][Full Text] [Related]
65. Circulating miRNAs as Potential Biomarkers for Celiac Disease Development. Tan IL; Coutinho de Almeida R; Modderman R; Stachurska A; Dekens J; Barisani D; Meijer CR; Roca M; Martinez-Ojinaga E; Shamir R; Auricchio R; Korponay-Szabó IR; Castillejo G; Szajewska H; Koletzko S; Zhernakova A; Kumar V; Li Y; Visschedijk MC; Weersma RK; Troncone R; Mearin ML; Wijmenga C; Jonkers I; Withoff S Front Immunol; 2021; 12():734763. PubMed ID: 34950132 [TBL] [Abstract][Full Text] [Related]
66. Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine. Yang X; Chen H; Chen Y; Birnbaum Y; Liang R; Ye Y; Qian J Cell Physiol Biochem; 2018; 50(2):552-568. PubMed ID: 30308506 [TBL] [Abstract][Full Text] [Related]
67. Circulating MicroRNA Profiles Differ between Hyperglycemia and Euglycemia in Coronary Heart Disease Patients. Jiang Y; Liu N; Xue B; Hou J; Lin C; Ren J; Liu J Biomed Res Int; 2017; 2017():9192575. PubMed ID: 29214180 [TBL] [Abstract][Full Text] [Related]
68. Diagnostic utility of circulating plasma microRNA-101a in severity of coronary heart disease. Yu H; Tu YF; Liu HM; Xu ME Ir J Med Sci; 2021 Nov; 190(4):1391-1396. PubMed ID: 33474702 [TBL] [Abstract][Full Text] [Related]
69. Circulating miRNAs and Risk of Sudden Death in Patients With Coronary Heart Disease. Silverman MG; Yeri A; Moorthy MV; Camacho Garcia F; Chatterjee NA; Glinge CSA; Tfelt-Hansen J; Salvador AM; Pico AR; Shah R; Albert CM; Das S JACC Clin Electrophysiol; 2020 Jan; 6(1):70-79. PubMed ID: 31971908 [TBL] [Abstract][Full Text] [Related]
70. Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19). Fayyad-Kazan M; Makki R; Skafi N; El Homsi M; Hamade A; El Majzoub R; Hamade E; Fayyad-Kazan H; Badran B Infect Genet Evol; 2021 Oct; 94():105020. PubMed ID: 34343725 [TBL] [Abstract][Full Text] [Related]
71. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
72. Elevated Plasma Levels of Circulating Extracellular miR-320a-3p in Patients with Paroxysmal Atrial Fibrillation. Zhelankin AV; Vasiliev SV; Stonogina DA; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429037 [TBL] [Abstract][Full Text] [Related]
73. Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease. Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P Medicine (Baltimore); 2018 Jul; 97(27):e11428. PubMed ID: 29979444 [TBL] [Abstract][Full Text] [Related]
74. Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy. Ji H; Yi Q; Chen L; Wong L; Liu Y; Xu G; Zhao J; Huang T; Li B; Yang Y; Li W; Han L; Duan S Clin Chim Acta; 2020 Feb; 501():147-153. PubMed ID: 31678272 [TBL] [Abstract][Full Text] [Related]
78. Circulating microRNAs as novel biomarkers for heart failure. Chen F; Yang J; Li Y; Wang H Hellenic J Cardiol; 2018; 59(4):209-214. PubMed ID: 29126951 [TBL] [Abstract][Full Text] [Related]
79. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia. Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404 [TBL] [Abstract][Full Text] [Related]
80. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease. Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]